Skip to Content

NeuroBo is focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. The company’s current pipeline consists of four programs targeting COVID-19, Neuropathic Pain, Alzheimer’s disease and Dementia.

PIPELINE

pipeline